{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/headache-tension-type/management/management/","result":{"pageContext":{"chapter":{"id":"2a5d2aeb-4fbe-58a2-a63b-587efa865dbd","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field 48b22fa1-5e27-4e84-8884-475bcde5c6bf --><h2>Scenario: Management of tension-type headache</h2><!-- end field 48b22fa1-5e27-4e84-8884-475bcde5c6bf -->","summary":"Covers the management of adults with episodic or chronic tension-type headache.","htmlStringContent":"<!-- begin item c7beb734-6ca5-4fd7-83be-8781a182ca32 --><!-- begin field 9bb1a4b4-7ca8-4318-a59f-acbc01599b49 --><p>From age 16 years onwards.</p><!-- end field 9bb1a4b4-7ca8-4318-a59f-acbc01599b49 --><!-- end item c7beb734-6ca5-4fd7-83be-8781a182ca32 -->","topic":{"id":"ce9a0483-27ca-546a-8341-b2eb62e827ca","topicId":"200fe157-d585-4a90-9cce-237592c693df","topicName":"Headache - tension-type","slug":"headache-tension-type","lastRevised":"Last revised in November 2017","chapters":[{"id":"81702389-3aa6-5a1b-86c6-e9d14e4c6357","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ad04034f-2189-5804-a9fc-6103cb10e039","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"bbc5032c-dd74-5182-83ae-c20554ab8a16","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"72b41351-2ec2-512d-ae64-5f7d4d914baf","slug":"changes","fullItemName":"Changes"},{"id":"9f3df9fc-bb2f-511b-b4a8-558a3e641a5d","slug":"update","fullItemName":"Update"}]},{"id":"3020ab6e-3cfa-56b9-b440-9c36f70010d2","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"cf533083-32c1-5bff-bb44-f2026050fb4e","slug":"goals","fullItemName":"Goals"},{"id":"b654b1d6-6268-5ca2-9fe4-e7becb8ee193","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bc215336-5373-5000-871e-da94c376977b","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"bc7f6e3b-d696-557b-ba7b-c114db0e6280","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"5de0c9ab-3ae3-57bf-889c-0e529bab2d21","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"0edc02ff-36b3-502c-9ad2-ddd4d78bd412","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"aed8a508-3b12-55c8-b919-4fe54c27359d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"1be3b000-e903-5a35-9228-7cb754c651a5","slug":"definition","fullItemName":"Definition"},{"id":"05585790-8533-5c81-9790-c4d555f68f8b","slug":"causes","fullItemName":"Causes"},{"id":"46de3224-b2eb-50f9-91c7-71b5b315296f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"5f776eec-ed2d-532a-81c0-63f0547c5ba0","slug":"complications","fullItemName":"Complications"},{"id":"4a39d4b5-144a-507a-886a-62a951a1fb64","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"26918b9e-7aa4-5e93-8e19-76cee1ce5319","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"9f22d183-bce4-5b38-bc36-886bc87b0256","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"705d4360-786c-570e-ba6a-309f615dc1f7","slug":"assessment","fullItemName":"Assessment"},{"id":"93961c34-9804-5e6e-bdca-b3ac4edb30dd","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"65be4311-7c21-5ea0-944a-b0dee19a7487","fullItemName":"Management","slug":"management","subChapters":[{"id":"2a5d2aeb-4fbe-58a2-a63b-587efa865dbd","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"662f0b99-d8bb-5d62-9bac-bf29d5a59f82","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"d94c43a3-4e48-502c-90e3-6686085f4d79","slug":"simple-analgesia","fullItemName":"Simple analgesia"}]},{"id":"f223b01e-92a1-5512-9f1a-6e0e67dfb1b3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"1b5e9777-ef7c-57d0-a8ed-caf0fb83c022","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"30d4c9f3-b910-50a9-bd60-e5ee078d00f5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0a992921-397a-5028-8324-71e175021e1f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6dc0bebe-c30b-5eb5-a4ad-d08911d0604d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d4c00b17-c57c-5875-9cc4-f34309ee2f3d","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"384992da-e3d7-5336-bdcc-9832e517d3b4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"71d40290-83c0-5fbc-852a-1e4110814e9f","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"65be4311-7c21-5ea0-944a-b0dee19a7487","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"62f00384-9b77-5fad-a24b-eff3e1c638c5","slug":"tension-type-headache","fullItemName":"Tension-type headache","depth":3,"htmlHeader":"<!-- begin field 71c3f6d6-162e-4289-874d-38d3b1f308ff --><h3>How should I manage tension-type headache?</h3><!-- end field 71c3f6d6-162e-4289-874d-38d3b1f308ff -->","summary":null,"htmlStringContent":"<!-- begin item 631d1625-c104-42b4-a37d-c9622b474403 --><!-- begin field be55ecf4-4126-4ad6-afb0-3927e76b5ead --><ul><li><strong>If the person has any red flags for a serious <a class=\"topic-reference internal-reference\" href=\"/topics/headache-tension-type/diagnosis/differential-diagnosis/\">secondary cause of headache</a>:</strong><ul><li>Refer to secondary care (with urgency depending on the clinical situation).</li><li>For information on red flags see the section on <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/diagnosis/headache-diagnosis/#red-flags\">warning features of serious causes of headache</a> in the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/\">Headache - assessment</a>.</li></ul></li><li><strong>If <a class=\"topic-reference internal-reference\" href=\"/topics/headache-tension-type/diagnosis/clinical-features/\">clinical features</a> are consistent with episodic tension-type (TTH) headache:</strong><ul><li>Offer simple analgesia such as paracetamol, aspirin or a nonsteroidal anti-inflammatory taking into account comorbidities and risk of adverse effects — advise the person to take a therapeutic dose as soon as possible after onset of attack.<ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a>.</li></ul></li><li>Do not offer opioids — if needed, reconsider the diagnosis.<ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/\">Headache - assessment</a>.</li></ul></li><li>Identify co-morbidities that may be associated with TTH such as stress, mood disorders, chronic pain and sleep disorders and manage appropriately.<ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>, <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a>, <a class=\"topic-reference external-reference\" href=\"/topics/obstructive-sleep-apnoea-syndrome/\">Obstructive sleep apnoea syndrome</a>, <a class=\"topic-reference external-reference\" href=\"/topics/osteoarthritis/\">Osteoarthritis</a> and <a class=\"topic-reference external-reference\" href=\"/topics/rheumatoid-arthritis/\">Rheumatoid arthritis</a>.</li></ul></li></ul></li><li><strong>If <a class=\"topic-reference internal-reference\" href=\"/topics/headache-tension-type/diagnosis/clinical-features/\">clinical features</a> are consistent with chronic TTH consider preventative treatment with:</strong><ul><li>A course of up to 10 sessions of acupuncture over 5–8 weeks.<ul><li>Acupuncture may not be easily accessible in primary care.</li></ul></li><li>Pharmacological prophylaxis with low dose amitriptyline (10-75mg daily) taking into account comorbidities and risk of adverse effects (this is an 'off-label' indication).<ul><li>For people who do not respond — discontinue treatment and discuss with neurology.</li><li>For people who do respond — attempt withdrawal of medication if improvement is maintained for 4–6 months.</li><li>For further information, see the <a class=\"topic-reference external-reference\" href=\"/topics/migraine/prescribing-information/\">Prescribing Section</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/migraine/\">Migraine</a>.</li></ul></li></ul></li><li><strong>Provide written and oral patient information on TTH:</strong><ul><li>Patient information on <a data-hyperlink-id=\"e2ad303b-9bbf-486c-a1d6-a98d003247d0\" href=\"https://www.nhs.uk/conditions/tension-headaches/\" target=\"_blank\">tension headaches</a> is available on the <a data-hyperlink-id=\"ff046f75-8d8e-4536-9401-a98d003247fd\" href=\"https://www.nhs.uk/conditions/\" target=\"_blank\">NHS</a> website.</li><li>Advise the person on the risk of medication overuse headache.<ul><li>People with frequent or chronic TTH may overuse medications to treat attacks and develop medication overuse headache.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/headache-medication-overuse/\">Headache - medication overuse</a>.</li></ul></li></ul></li><li><strong>If co-existence of TTH and migraine without aura or medication overuse headache is suspected</strong>:<ul><li>Advise the person to keep a headache diary recording frequency, severity, characteristics, and duration of attacks along with effectiveness of medications used to help differentiate between headache types.<ul><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/\">Headache - assessment</a>, <a class=\"topic-reference external-reference\" href=\"/topics/headache-medication-overuse/\">Headache - medication overuse</a> and <a class=\"topic-reference external-reference\" href=\"/topics/migraine/\">Migraine</a>.</li></ul></li></ul></li><li><strong>If uncertain about diagnosis/management or first line measures in primary care fail</strong> — discuss with a neurologist or GP with a special interest in headache.</li></ul><!-- end field be55ecf4-4126-4ad6-afb0-3927e76b5ead --><!-- end item 631d1625-c104-42b4-a37d-c9622b474403 -->","subChapters":[{"id":"ce7b864a-1273-5549-84e5-7e3a90e961c9","slug":"basis-for-recommendation-198","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4ca5cb68-5a03-4af2-8581-274a67da601b --><h4>Basis for recommendation</h4><!-- end field 4ca5cb68-5a03-4af2-8581-274a67da601b -->","summary":null,"htmlStringContent":"<!-- begin item 198ba79a-b43c-4611-912a-e67315ce7ff1 --><!-- begin field 6c865cb9-0092-4ba1-8a6b-aa6bcbcffd98 --><p>The recommendations on management of tension-type headache (TTH) are based on the clinical guidelines <em>Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">BASH, 2010</a>], <em>Headaches in over 12s: diagnosis and management (updated November 2015)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">NICE, 2012</a>], <em>The International Classification of Headache Disorders, 3rd edition (beta version)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">IHS, 2013</a>], <em>Diagnosis and treatment of headache</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">ICSI, 2013</a>] and <em>Guideline for primary care management of headache in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Becker, 2015</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Beran, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Hale, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Yancey, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Dowson, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Green, 2016</a>].</p><h5>Acute treatment</h5><ul><li>Several clinical guidelines including those from The British Association for the Study of Headache (BASH) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">BASH, 2010</a>], The National Institute for Health and Care Excellence (NICE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">NICE, 2012</a>],  the Institute for Clinical Systems Improvement (ICSI) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">ICSI, 2013</a>] and the Institute of Health Economics (Alberta, Canada) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Becker, 2015</a>]  recommend simple analgesia such as aspirin, paracetamol or nonsteroidal anti-inflammatories for the acute treatment of tension-type headache (TTH). The person's preference, comorbidities and risk of adverse events should be taken into account.<ul><li>A Cochrane review of 23 studies (n = 8079) found that paracetamol 1000 mg provided a small benefit in terms of being pain free at two hours for people with frequent episodic TTH of moderate or severe intensity. NNT for the outcome pain-free at two hours for paracetamol 1000 mg compared with placebo was 22 (95% CI 15–40) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Stephens, 2016</a>]. </li><li>A Cochrane review of 12 studies (n=3094) concluded that ibuprofen 400 mg may relieve headache pain in people with frequent episodic tension-type headache who have an acute headache with moderate or severe initial pain, but the chance of the pain being entirely relieved by 2 hours was low [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Derry, 2015</a>].</li></ul></li><li>Guidelines from BASH and NICE recommend avoidance of opioids in the acute treatment of TTH [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">BASH, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">NICE, 2012</a>].<ul><li>Evidence on the effectiveness of opioids in the acute treatment of TTH is lacking and the recognised side effects of opioids including an increased risk of medication overuse headache are considerable [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">NICE, 2012</a>].</li></ul></li></ul><h5>Preventative treatment for chronic TTH</h5><ul><li>Acupuncture<ul><li>NICE recommend a course of up to 10 sessions of acupuncture over 5–8 weeks. There is some evidence from single-blind studies that acupuncture reduces the number of headache days compared with sham acupuncture. Although evidence was of low quality, the NICE Guideline Development Group agreed that, because they found very little evidence to support the use of pharmacological prophylaxis, this evidence was sufficient to recommend its use [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">NICE, 2012</a>].</li><li>A Cochrane review including 12 trials (n=2,349) concluded that acupuncture may be considered for treating frequent episodic or chronic tension-type headaches [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Linde, 2016</a>]. <ul><li>Acupuncture was compared with routine care of acute headaches in two large trials (1265 and 207 participants). The proportion with at least 50% reduction in headache frequency was higher in groups receiving acupuncture than in control groups (trial 1: 48% versus 19% [RR 2.5: 95% CI 2.1–3.0]; trial 2: 45% versus 4% [RR 11: 95% CI 3.7–35]).</li><li>Acupuncture was compared with sham acupuncture in seven trials; five large studies provided data for one or more meta-analyses. Among participants receiving acupuncture, 51% had at least 50% reduction of headache frequency compared to 43% in the sham group after treatment (RR 1.3 [95% CI 1.09–1.5]).</li></ul></li><li>CKS recognizes that in many areas there may be restrictions on commissioning acupuncture services [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">DTB, 2010</a>]. It should also be noted that the evidence reviewed by NICE was for the traditional Chinese medicine approach to acupuncture [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">NICE, 2012</a>], whereas many GPs, nurses, and physiotherapists in the NHS use medical acupuncture rather than the traditional Chinese medicine approach [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">DTB, 2010</a>].</li><li>The British Association for the Study of Headache (BASH) state in their guideline on headache that the role of acupuncture is unproven but it may be worth trying in the absence of other options [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">BASH, 2010</a>].</li></ul></li><li>Amitriptyline<ul><li>The NICE guideline on headache [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">NICE, 2012</a>] does not recommend amitriptyline for prevention of chronic tension-type headache due to a lack of evidence.</li><li>Several other guidelines such as those from BASH [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">BASH, 2010</a>], the Institute for Clinical Systems Improvement [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">ICSI, 2013</a>], and the Institute of Health Economics (Alberta, Canada) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Becker, 2015</a>] recommend amitriptyline for chronic TTH. However, guidance states that evidence does not establish how best to use this drug, or in what dose [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">BASH, 2010</a>].</li><li>Expert opinion in several review articles is that evidence for low dose tricyclic antidepressants in reduction of frequency and intensity of attacks in people with chronic TTH is variable [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Hale, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Green, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Ghadiri-Sani, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Lozano Lopez, 2016</a>].</li><li>A systematic review and meta-analysis including 22 randomized controlled trials found that tricyclic antidepressants are modestly effective in reducing chronic tension-type headache frequency compared to placebo (weighted mean differences: -4.8 headaches/month, 95% CI: -6.63 to -2.95) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Jackson, 2017</a>].</li></ul></li></ul><h5>Patient information and education</h5><ul><li>Expert opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">NICE, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">ICSI, 2013</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Yancey, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Dowson, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">Probyn, 2017</a>] is that patient education on TTH and effective self-management is essential.</li><li>The guideline from ICHD highlights the importance of distinguishing between frequent episodic tension-type headache and migraine without aura which often co-exist. Patient education allows the person to more accurately identify headache type, select the appropriate treatment and reduce the risk of medication-overuse headache [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-tension-type/references/\">IHS, 2013</a>].</li></ul><!-- end field 6c865cb9-0092-4ba1-8a6b-aa6bcbcffd98 --><!-- end item 198ba79a-b43c-4611-912a-e67315ce7ff1 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}